Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$9.06

Avg closing price
Price range

10 Jim Simons Nuvectis Pharma Trades

The first Nuvectis Pharma trade was made in Q2 2023. Since then Jim Simons bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q3 2025 and Q4 2025.

Avg closing price
Price range
Sold -42.8k shares Q4 2025
Avg closing price $6.51
Price range $5.65 - $8.26
Sold 0.5% shares (-200 shares) Q3 2025
Avg closing price $6.88
Price range $5.92 - $8.28
New holding (+43k shares) Q2 2025
Avg closing price $9.06
Price range $7.47 - $10.96
Sold -15.8k shares Q4 2024
Avg closing price $6.21
Price range $4.52 - $10.98
Sold 78.8% shares (-58.7k shares) Q3 2024
Avg closing price $6.58
Price range $6.16 - $7.23
Increased shares by 20.7% (+12.8k shares) Q2 2024
Avg closing price $6.80
Price range $5.98 - $8.25
Increased shares by 19.1% (+9.9k shares) Q1 2024
Avg closing price $8.50
Price range $6.69 - $11.00
Increased shares by 103.9% (+26.4k shares) Q4 2023
Avg closing price $8.92
Price range $7.85 - $11.78
Sold 30.2% shares (-11k shares) Q3 2023
Avg closing price $14.49
Price range $12.89 - $16.29
New holding (+36.4k shares) Q2 2023
Avg closing price $15.96
Price range $12.62 - $18.40

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!